1.Intralesional Bleomycin Therapy Using a Lancet in the Treatment of Recalcitrant Warts.
Won Ho KIM ; Chul Woo KIM ; Kwang Ho KIM ; Kwang Joong KIM
Annals of Dermatology 2005;17(2):53-57
No abstract available.
Bleomycin*
;
Warts*
2.Four cases of massive infiterating congenital cystic hygroma managed by bleomycin sclerosing therapy.
Hyun KWACK ; Dong Wook KIM ; Kyung Woon NO ; Jun HEO ; Sun Young KIM ; Young Pyo JANG ; Jung Hwan CHOI ; Chong Ku YUN ; Seong En JUNG ; Gui Won PARK ; Woo Gi KIM ; Kyung Mo YEON
Journal of the Korean Pediatric Society 1992;35(8):1148-1156
No abstract available.
Bleomycin*
;
Lymphangioma, Cystic*
3.Postoperative Intratumoral Injection of Bleomycin for Cystic Craniopharyngioma.
Soo Han YOON ; Joong Uhn CHOI ; Eun Young KIM
Journal of Korean Neurosurgical Society 1993;22(11):1175-1183
Surgical excision or irradiation of craniopharyngioma is problematic because both are often associated with high risk of complications. Three cases of cystic craniopharyngioma were subtotally removed by surgery and followed by repeated injection of bleomycin into the remaining tumor cavity as postoperative adjuvant therapy. With bleomycin injection, tumors were shrunk postoperatively in two cases out of three ut in one case cyctic portion became increased in size progressively which needed second operation and irradiation. Bleomycin injection could be considered as one of the reasonable alternative adjuvant therapies for incompletely removed cystic craniopharyngioma before radiation therapy.
Bleomycin*
;
Craniopharyngioma*
;
Drug Therapy
4.Preliminary Study of Intralesional Bleomycin Injection for the Treatment of Genital Warts.
Jin Yong LEE ; Chul Woo KIM ; Sang Seok KIM
Annals of Dermatology 2015;27(2):239-241
No abstract available.
Bleomycin*
;
Condylomata Acuminata*
6.Treatment of cystic lymphangioma with topical use of bleomycin in childhood.
Han Cheol CHOI ; Young Wook KIM ; Soo Il CHANG
Journal of the Korean Surgical Society 1993;44(4):598-604
No abstract available.
Bleomycin*
;
Lymphangioma, Cystic*
7.Bleomycin sclerotherapy in patients with lymphatic malformation.
Myung Whun SUNG ; Sun O CHANG ; Seung Ha OH ; Jong Woo CUNG ; Young Seok CHOI ; Jin Young KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(6):1294-1298
No abstract available.
Bleomycin*
;
Humans
;
Sclerotherapy*
8.A case of cystic hygroma managed by bleomycin sclerosing therapy.
Sun O CHANG ; Seung Ha OH ; Ha Won JUNG
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(4):842-846
No abstract available.
Bleomycin*
;
Lymphangioma, Cystic*
9.Combination Therapy with Pulsed Dye Laser and Intralesional Bleomycin for the Treatment of Recalcitrant Warts.
Seok Yeol PARK ; Chang Duk KIM ; Chang Wook KIM ; Kyu Suk LEE
Korean Journal of Dermatology 2005;43(5):638-642
BACKGROUND: Some warts prove resistant to multiple therapies, particularly on an immunosuppressed patient. A previous study revealed that combination therapy with pulsed dye laser and intralesional bleomycin was effective on recalcitrant warts. OBJECTIVE: The aim of this study was to confirm whether the combination therapy with pulsed dye laser and intralesional bleomycin was effective for the treatment of recalcitrant warts. METHOD: Fifteen patients, all with recalcitrant warts, were recruited. Two patients were on long-term immunosuppressant drugs. Twenty warts were treated in total. The warts were anaesthetized with local anesthetic cream (EMLA(R) 5% cream) then treated with a pulsed dye laser (5mm spot, fluence 9.5-10J/cm2). Immediately following this, bleomycin (1mg/ml) was injected into the base of the warts. At 3-4 weeks after the last treatment, the warts were evaluated to assess clearance rate, total treatment numbers and side effects. RESULT: 1. Complete clearance was achieved for 17 out of 20 warts (85%). 2. Partial clearance was achieved for 3 out of 20 warts (15%). 3. Recalcitrant warts were cleared with an average of 1.95 treatments. 4. Recalcitrant warts on the immunosuppressed patients were cleared with an average of 2.0 treatments. 5. No significant side effects were observed. CONCLUSION: Combination therapy with the pulsed dye laser and intralesional bleomycin appears to be a safe, rapid, well tolerated and successful treatment for recalcitrant warts. It also appears to be effective for recalcitrant warts on immunosuppressed patients.
Bleomycin*
;
Humans
;
Lasers, Dye*
;
Warts*
10.Bleomycin induced pulmonary toxicities during chemotherapy in patients with cervical cancer.
Jin Woong SHIN ; Bong Tae MOON ; Kyung Sun HONG ; Kyung Sook LEE ; Nan Ju JEONG ; Se Il KIM ; Sung Eun NAMKOONG ; Seung Jo KIM
Korean Journal of Obstetrics and Gynecology 1992;35(2):286-291
No abstract available.
Bleomycin*
;
Drug Therapy*
;
Humans
;
Uterine Cervical Neoplasms*
Result Analysis
Print
Save
E-mail